7 Einträge gefunden

1. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.

   1. Weischenfeldt, Joachim
   2. Simon, Ronald
   3. Feuerbach, Lars
   4. Schlangen, Karin
   5. Weichenhan, Dieter
   6. Minner, Sarah
   7. Wuttig, Daniela

   2013 - Forschungsinformationssystem des UKE
2. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

   1. Grupp, Katharina
   2. Sanader, Stella
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Koop, Christina
   6. Prien, Kristina
   7. Hube-Magg, Claudia

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
3. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

   1. Flammiger, Anna
   2. Weisbach, Lars
   3. Huland, Hartwig
   4. Tennstedt, Pierre
   5. Simon, Ronald
   6. Minner, Sarah
   7. Bokemeyer, Carsten

   2013 - Forschungsinformationssystem des UKE
4. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

   1. Tsourlakis, Maria Christina
   2. Schoop, Michael
   3. Plaß, Christoph
   4. Huland, Hartwig
   5. Graefen, Markus
   6. Steuber, Thomas
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
5. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

   1. Stumm, Laura
   2. Burkhardt, Lia
   3. Steurer, Stefan
   4. Simon, Ronald
   5. Adam, Meike
   6. Becker, Andreas
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
6. Marked heterogeneity of ERG expression in large primary prostate cancers.

   1. Minner, Sarah
   2. Gärtner, Michael
   3. Freudenthaler, Fabian
   4. Bauer, Melanie
   5. Kluth, Martina
   6. Salomon, Georg
   7. Heinzer, Hans

   2013 - Forschungsinformationssystem des UKE
7. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

   1. Grupp, Katharina
   2. Kohl, Sebastian
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Steurer, Stefan
   6. Becker, Andreas
   7. Adam, Meike

   2013 - Forschungsinformationssystem des UKE